» Articles » PMID: 26119440

A Case of Paraneoplastic Bullous Pemphigoid in Association with Squamous Cell Carcinoma of Lung

Overview
Journal J Postgrad Med
Specialty General Medicine
Date 2015 Jun 30
PMID 26119440
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Bullous pemphigoid is a chronic, autoimmune, acquired subepidermal blistering disorder. It is idiopathic in origin, and mainly seen in elderly individuals. Association between bullous pemphigoid and internal malignancies is reported in the literature, but the exact causal relation is not established. Paraneoplastic bullous pemphigoid is rarely reported in lung cancers, especially in squamous cell variety. So their presence should raise the suspicion of various internal malignancies including lung cancer. It is presented mainly with tense, large blisters over the erythematous base or over normal skin. Subepidermal blisters with tissue eosinophilia are characteristic histopathological features of bullous pemphigoid. Direct immunofluorescence shows linear deposits of IgG - complement complex along the dermoepidermal junction. Conventional treatment of bullous pemphigoid along with treatment of lung cancer (surgery, chemotherapy, radiotherapy) may result in successful resolution of skin lesions. Here, we report a rare association of paraneoplastic bullous phemphigoid and squamous cell carcinoma of lung in a 76-year-old male to increase the awareness among the clinicians regarding this variety of cutaneous paraneoplastic manifestation of lung cancer.

Citing Articles

Resolution of Bullous Pemphigoid Following Lung Cancer Resection: A Case of Paraneoplastic Pemphigoid.

Youh J, Mizukami T, Nagata Y, Ito K Cureus. 2024; 16(11):e73485.

PMID: 39669836 PMC: 11635038. DOI: 10.7759/cureus.73485.


Pembrolizumab therapy in a patient with NSCLC and bullous pemphigoid: A case report.

Li A, Li F, Ma Z, Pang Y, Deng B, He Z Oncol Lett. 2024; 28(4):470.

PMID: 39139747 PMC: 11319822. DOI: 10.3892/ol.2024.14603.


Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid.

Baum S, Steinberg S, Tzanani I, Barzilai A, Lyakhovitsky A Acta Derm Venereol. 2023; 103:adv00888.

PMID: 36916952 PMC: 10026015. DOI: 10.2340/actadv.v103.3979.


A Case of Bullous Pemphigoid Associated With Nivolumab Therapy.

Gotera N, Weilg P, Heleno C, Ferrari-Gabilondo N Cureus. 2022; 14(5):e24804.

PMID: 35686260 PMC: 9169882. DOI: 10.7759/cureus.24804.


Bullous pemphigoid associated with squamous cell lung carcinoma showing remarkable response to carboplatin-based chemotherapy:  a case report.

Shrestha P, George M, Baidya S, Rai S J Med Case Rep. 2022; 16(1):184.

PMID: 35513831 PMC: 9074342. DOI: 10.1186/s13256-022-03323-9.


References
1.
Thoma-Uszynski S, Uter W, Schwietzke S, Hofmann S, Hunziker T, Bernard P . BP230- and BP180-specific auto-antibodies in bullous pemphigoid. J Invest Dermatol. 2004; 122(6):1413-22. DOI: 10.1111/j.0022-202X.2004.22603.x. View

2.
Robak E, Robak T . Skin lesions in chronic lymphocytic leukemia. Leuk Lymphoma. 2007; 48(5):855-65. DOI: 10.1080/10428190601137336. View

3.
Iranzo P, Lopez I, Robles M, Mascaro Jr J, Campo E, Herrero C . Bullous pemphigoid associated with mantle cell lymphoma. Arch Dermatol. 2004; 140(12):1496-9. DOI: 10.1001/archderm.140.12.1496. View

4.
Iuliano L, Micheletta F, Natoli S . Bullous pemphigoid: an unusual and insidious presentation of breast cancer. Clin Oncol (R Coll Radiol). 2003; 15(8):505. DOI: 10.1016/j.clon.2003.08.006. View

5.
Egan C, Lazarova Z, Darling T, Yee C, Cote T, Yancey K . Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet. 2001; 357(9271):1850-1. DOI: 10.1016/S0140-6736(00)04971-0. View